Objective: To assess the effects of drug-induced changes in mean transit time (MTT) on the activity of human fecal¯ora in vitro. Methods: The activity of fecal¯ora was estimated by the ability of a fecal inoculum to ferment a substrate (beet ®ber) in vitro in a batch system for 24 h. The inoculum was collected from 8 healthy volunteers studied during three 3-week randomized periods, who received a controlled diet alone (control period) or the same diet with either cisapride or loperamide. Cisapride and loperamide were adjusted in order to halve and double MTT measured during the control period. At the end of each period, the percentage disappearance of the initial added substrate and the concentration and the pro®le of short-chain fatty acids (SCFAs), were determined. Results: In the control period, the pH of the inoculum and SCFA concentration were inversely related to MTT (P 0.0001). Individual SCFA production was also signi®cantly related to MTT (P`0.01). Cisapride-reduced transit time was associated with a signi®cant rise in the concentrations of total SCFAs (P`0.05), propionic and butyric acids (P`0.05) and the percentage substrate disappearance (P`0.05). Inverse relations were observed during the loperamide period. Moreover, MTT was inversely related to the percentage substrate disappearance (P`0.001), SCFA production (P`0.001) and butyrate production (P`0.0005). Conclusion: Changes in MTT alter bacterial activity and modify the bacterial pathways affecting the proportion of individual SCFAs. Sponsorship:
Introduction
Human fecal bacteria are representative of those occurring in different regions of the large bowel, relative to the generic distribution and relative proportion of species (Moore et al, 1978) . The majority of species in the colon use the Embden ± Meyerhoff ± Parnas pathway and produce short-chain fatty acids (SCFAs) (acetate, propionate and butyrate), and carbon dioxide and hydrogen gases as the principal end-products (Wolin & Miller, 1983) .
The type of fermentation products depends on the chemical composition of the polysaccharide substrate and the rate and extent to which it is broken down (Macfarlane & Macfarlane, 1993) ; the type of¯ora involved and its growth rate (Macfarlane & Macfarlane, 1993) ; the ef®-ciency of hydrogen removal (Thauer, 1976) and thus the amount and type of hydrogen consuming-bacteria in the colon (methanogenic, acetogenic or sulfate-reducing bacteria); and host factors such as transit time. The last factor seems to be of particular importance since it can in¯uence the extent and activity of gut bacteria. Indeed, in in vitro continuous culture, in which bacteria are grown with a constant substrate supply, bacterial cell growth (Isaacson et al, 1975; Kotarski & Salyers, 1981; Silley & Amstrong, 1984) and the pattern of fermentation products (Kotarski & Salyers, 1981; Silley & Amstrong, 1984 ) depend on turnover time. Moreover, it has been shown in vivo, in both ruminant and man that the ef®ciency of anaerobic microbial growth is dependent on the rate of passage of material through the fermentation system (Owens & Isaacson, 1977; Stephen et al, 1987) . With a faster turnover rate, microbial growth is more ef®cient and a greater mass of bacteria is produced (Stephen et al, 1987) . Conversely, with a lower turnover rate, the ef®ciency of microbial growth decreases (Stephen et al, 1987) while methanogenic bacteria as well as the pH of luminal contents increase (El Ou®r et al, 1996) . Therefore, transit time through the colon could markedly in¯uence the extent of ®ber fermentation and the types of fermentation end-products. This hypothesis was tested here by studying the bacterial fermentation of a well-known dietary ®ber-rich substrate (beet sugar) in an in vitro device inoculated with human fecal bacteria. Fecal inocula were collected from healthy volunteers with either spontaneous or pharmacologically modi®ed transit time.
Materials and methods

General design
The general protocol, derived from the study of Stephen et al (1987) , consisted of three 3-week experimental periods. After an initial control period, subjects received either cisapride or loperamide in random order during two subsequent 3-week periods, in order to speed up or slow down intestinal transit. During each period, subjects ingested the same controlled diet and collected their stools. Ingested radiopaque pellets were used for MTT measurement. Feces were used to inoculate an in vitro fermenter for the study of dietary ®ber fermentation. The protocol was approved by the local ethics committee, and all investigations were undertaken after informed consent was given by the subjects.
Subjects
Eight healthy adult volunteers (3 males and 5 females, 26 ± 35 years of age) participated in the study. None had received antibiotics, laxatives or enemas during the previous 3 months. On the basis of breath methane (CH 4 ) concentrations, which were at least 1 part per million (ppm) above room atmosphere, 4 volunteers were identi®ed as methane excretors (CH 4 ) and 4 as methane non-excretors (CH 4 7 ).
Diets
Men and women consumed different diets consisting in each case (in rotation) of ®ve one-day isocaloric menus of similar composition. Daily energy intake was 8.36 MJ (2000 kcal) (consisting of 79 g protein, 91 g fat and 223 g carbohydrate) for women and 10.45 MJ (2500 kcal) (consisting of 81 g protein, 92 g fat and 311 g carbohydrate) for men. Additional carbohydrates in men were obtained from foods containing short carbohydrates. Both diets were designed to contain a high level of dietary ®ber (30 g), which would induce a short transit time in the control period and could then be altered during the loperamide treatment without distress to the participants.
Experimental design
Cisapride (10 mg tablets) (Prepulsid, Janssen, Boulogne, France) and loperamide (2 mg tablets) (Imodium, Janssen, Boulogne, France) were used respectively to speed up and slow down transit. Drug therapy was titrated to roughly double or halve the spontaneous transit time of subjects. For cisapride, two tablets (one with breakfast and the other with dinner) were given initially. The dose was then increased by one tablet per day up to 60 mgaday if the expected effect was not achieved. For loperamide, two tablets were used initially, and the dose was increased up to 10 mgaday until the expected effect was achieved. All adjustments were made during the ®rst week of each period. The ®nal daily drug doses were 40 mg (n 2) and 60 mg (n 6) for cisapride, and 6 mg (n 1), 8 mg (n 4) and 10 mg (n 3) for loperamide. Throughout the study, subjects ingested 30 radiopaque pellets daily (10 per meal) as nonabsorbable markers. Two marker shapes were used: small squares and circles. The type of marker was changed at the end of each 3 week period, so that total marker recovery during each period could be estimated. Subjects collected stools throughout the study and for one week afterwards in order to assess the total recovery of ingested markers. Stools were collected from days 14 to 21 of each period for determination of the average MTT value of the last 7 days of each experimental period. Each stool was collected separately in a plastic bag suspended over a toilet and then weighed. The dry matter content was determined after freeze-drying of an aliquot. At the end of each of the three experimental periods, fresh feces (control feces, cisapride feces and loperamide feces, respectively) were collected for in vitro fermentation studies.
In vitro fermentation
All experiments were conducted in vitro in a batch system according to the general procedure described by Barry et al (1996) , using serum bottles instead of vials so that gas could be collected. Fresh feces were mixed (1:5, wav) with a CO 2 -saturated nutritive buffer (Table 1) , then ®ltered through six gauzes to remove undigested materials. During inoculum preparation, fecal contents, solutions and containers were kept under a constant¯ow of oxygen-free CO 2 . For each experimental time, two batches of ®ber were prepared by mixing 400 mg of ®ber (beet ®ber, Ge Âne Ârale Sucrie Áre, France) with 20 ml of human fecal inoculum in an oxygen-free nitrogen atmosphere. A batch containing inoculum without any substrate was used as a control. At time 0, all batches were put into a shaking water bath at 40 C, and fermentation was studied for 6, 12 or 24 h. Total gas production was measured hourly until 6 h, then at 12 and 24 h. At the end of each experimental time, fermentations were stopped by adding 0.1 ml HgCl 2 (100 gal). Gas was collected for further hydrogen and methane concentration determinations, and the pH of the slurries was measured. The bottles were then rinsed with 20 ml of distilled water. The mixture was centrifuged for 10 min at 5000 g, and 4.5 ml of supernatants were added to 0.5 ml of phosphoric acid for SCFA determination. Pellets obtained at 24 h were freeze-dried for further cell wall carbohydrate determination.
Analysis
Transit time measurement: Markers were counted in stools by radiography. Transit time measurements were calculated using the continuous marker technique described by Cummings et al (1976) , which allows continuous dayby-day MTT measurement.
Gas: Hydrogen and methane were quanti®ed by chromatography using a Quintron Microlyser model DP (Quintron Instruments Co, MI, USA).
Short-chain fatty acids: Short-chain fatty acids were quanti®ed by GLC according to the procedure described by Jouany (1982) . Cell wall carbohydrates: Neutral cell wall carbohydrates were quanti®ed after sulfuric hydrolysis according to the chromatographic method described by Hoebler et al (1989) . Uronic acids were quanti®ed by the colorimetric method described by Thibault (1979) .
Calculations and statistical analysis
The fermentability of each carbohydrate was calculated as follows:
where S 0 is the amount of added carbohydrate, S b is the amount of carbohydrate in the blank, and S t is the residual amount of carbohydrate at time t of fermentation.
The monosaccharides quanti®ed in both native and fermented ®bers were expressed as polymers (0.96 weight of monosaccharide).
The production of each SCFA was calculated as follows for each experimental time:
where S i and S 0 are SCFA concentration values in vials containing substrates at time 0 and i respectively. SCFAs were expressed as mmolal.
For each experimental time, total SCFA production was calculated as the sum of the individual production of acetic, propionic, butyric, isobutyric, valeric and isovaleric acids. SCFA ratios were calculated for acetic, propionic and butyric acids and expressed as molar percentages of the sum of the production of these acids.
Statistical analysis
One-way analysis of variance and paired t-tests were used to compare means from the three periods. Correlations between log MTT and each parameter were analyzed by simple regression. Student's unpaired t-test was used to compare data between methane excretors and non-excretors. All statistical tests were performed with Statview II software.
Results
Mean transit time
Results concerning transit time variations and their implications for in vivo fermentation parameters were reported in a previous publication (El Ou®r et al, 1996) , but the main points are included here to ensure a better understanding of the relation of transit time modi®cations to other measured parameters.
During the control period, MTT ranged from 41 to 122 h, and was signi®cantly longer in CH 4 than CH 4 7 (98 AE 10 vs 47 AE 5 h; P`0.05). MTT changes during cisapride and loperamide periods are shown in Figure 1 . Compared to the control period, MTT was signi®cantly shortened by cisapride (47 AE 5 vs 73 AE 11 h, P`0.05) and signi®cantly lengthened by loperamide (147 AE 12 vs 73 AE 11 h, P`0.001).
Characteristics of inocula and fermentation parameters During the control period: The mean characteristics of inocula at time 0 during the control period are shown in Table 2 . pH and SCFA concentration at time 0 differed signi®cantly between CH 4 and CH 4 7 . Moreover, these factors were inversely related to MTT (r 0.98, P 0.0001, n 8; r 70.99, P 0.0001, n 8, respectively). The proportions of acetate, propionate and butyrate in inocula were signi®cantly related to log MTT (r 0.93, P 0.0008, n 8; r 7 0.95, P 0.0002, n 8; and r 7 0.90, P 0.003, n 8, respectively). During the fermentation of beet ®ber, pH, non-starch polysaccharide (NSP) degradation and SCFA production varied, as shown in Table 3 . At all experimental times, these parameters differed signi®cantly between CH 4 and CH 4 7 , pH being lower and SCFA production and NSP degradation higher in CH 4 7 than in CH 4 . In addition, 24 h SCFA production and 24 h NSP degradation were inversely related to MTT (r 70.98, P 0.0001, n 8; r 70.078, P 0.02, n 8, respectively).
The relative proportions of the main SCFAs are presented in Table 4 . Signi®cant differences due to CH 4 excretor status were observed for acetic, propionic and butyric acid proportions (P`0.05 at 6, 12 and 24 h) ( Table 4 ). The proportions of acetate and butyrate produced at 24 h were closely correlated with MTT (r 0.96, P 0.0001, n 8; r 70.92, P 0.001, n 8, respectively).
During the cisapride period: pH and SCFAs were affected by CH 4 status, as during the control period (Table 2 ). Compared to the control period, fecal pH decreased (P`0.05, n 8), while fecal SCFAs signi®-cantly increased with cisapride (P`0.05, n 8) ( Table 2) .
The changes in the fermentation pattern induced during the cisapride period are shown in Table 3 . The use of . { P`0X05 vs control period.
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Compared to results for the control period, the use of feces from the cisapride period signi®cantly decreased the proportion of acetate at 24 h (P`0.05) and signi®cantly increased the proportion of butyrate (P`0.05). The increased proportion of propionate was not signi®cant (P 0.07).
During the loperamide period: pH and SCFA production varied according to methane status, as previously observed (Table 2 ). Compared to the control period, fecal pH increased, but not signi®cantly, while fecal SCFAs signi®-cantly decreased (P`0.05) with loperamide ( Table 2 ).
The changes in the fermentation pattern induced during the loperamide period are shown in Table 3 . The use of loperamide feces signi®cantly decreased SCFA production and NSP degradation at all time-points (Table 3) .
The use of loperamide feces signi®cantly increased the proportion of acetate (72.5 AE 1.4 vs 66.7 AE 2.0, P`0.05) and decreased the concentration of butyrate (8.0 AE 0.4 vs 10.5 AE 0.7, P`0.05). The decrease in the proportion of propionate did not reach statistical signi®cance (15.2 AE 1.4 vs 19.1 AE 1.9, P 0.07).
During the three periods, the characteristics of inocula were highly correlated with MTT: fast transit time was associated with low pH (r 7 0.91), high SCFA concentration (r 0.91), low proportions of acetate (r 70.97) and a high proportion of propionate (r 0.95) and butyrate (r 0.89). ). *Signi®cantly different (P`0.05) vs control period. 
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When these inocula were used for in vitro fermentation of a model ®ber, fermentation parameters were highly correlated with the MTT of donors. Fast transit times were associated with rapid pH decrease (r 0.84), high NSP degradation (r 0.74) (Figure 2 ), high SCFA production (r 0.90) (Figure 3) , a decreased ratio of acetate and an increased ratio of propionate and mainly butyrate (r 0.90, P 0.0007, n 24; r 0.40, P 0.05, n 24; r 0.83, P 0.0001, n 24, respectively) (Figure 4 ).
Discussion
Our results show that transit changes alter not only the characteristics of inocula but also certain fermentation parameters. During the control period, we observed a strong correlation between the spontaneous transit time of subjects and the characteristics of inocula. Subjects with fast MTT (CH 4 7 ) had a lower pH and a higher fecal concentration of SCFAs than those with slow gut transit (CH 4 ). This con®rms that MTT is related to fecal pH (Stephen et al, 1986) . Speeding up transit by pharmacological means also produced lower fecal pH, whereas SCFA concentrations rose. The reverse was true when transit was slowed down by loperamide. It would appear that fast transit time through the large bowel impedes SCFA absorption (less time for absorption), leading to sustained acidi®cation of the contents and increased fecal excretion of SCFAs. Transit variations could also induce changes in fecal amounts of SCFAs because of alterations in substrates owing to the colon andaor changes in the environmental conditions of the large intestine (such as pH). As fast MTT was associated with fast orocoecal transit time in both control and cisapride periods in our previous study (El Ou®r et al, 1996) , this may have enhanced the delivery of fermentable substrates to the colon. As dietary ®ber and resistant starch are not degraded in the small intestine, it is likely that the amount entering the large intestine was constant during the three periods. However, digestible nutrients, in particular digestible starch, may have been less ef®ciently absorbed in the small intestine when transit time was shortened (Holgate & Read, 1983; Chapman et al, 1985) .
In addition to these modi®cations in the characteristics of inocula, our data show that transit changes alter the parameters of fermentation. In the control period, spontaneous MTT was inversely related to SCFA production and NSP degradation after 24 h incubation with a fecal inoculum from the 8 healthy volunteers. SCFA production and NSP degradation were signi®cantly increased with cisapride but only slightly reduced during loperamide administration. The rise in SCFA production and NSP degradation during faster transit can be explained by the increased amount of exogenous and endogenous fermentable material¯owing into the large bowel and thus potentially available as substrate for bacteria. Indeed, Stephen et al (1987) have shown that the colonic micro¯ora responds to increase in fermentable carbohydrate supply by increasing cell numbers and mass. However, substrate supply is not the only factor accounting for changes in the size or activity of the fecal¯ora. Numerous studies performed with ruminal¯ora either in vitro or in vivo have shown that the ef®ciency of anaerobic microbial growth is dependent not only on substrate availability but also on the rate of passage of material through the fermentation system. The faster the turnover rate, the more ef®cient microbial growth is and the Transit time and in vitro fermentation L El Ou®r et al greater the mass of bacteria produced. This is clearly discussed by Stephen et al (1987) . In a previous study (El Ou®r et al, 1996) , we determined the number of total anaerobes per gram of feces: no signi®cant changes were found between the three periods, although counts tended to increase during the cisapride period.
Transit time changes may have altered not only the extent of the gut micro¯ora but also its metabolic activities, since the pattern of SCFA production was signi®cantly affected during in vitro fermentation of the same substrate. Indeed, during the control period, signi®cant differences were observed among subjects for acetic, propionic and butyric acids. MTT was closely related to the proportion of acetate produced and inversely related to that of propionic and butyric acids.
Transit variation could have induced changes in the proportion of SCFAs because of alteration in the nature of substrates¯owing to the large bowel. Indeed, digestible starch may have been less ef®ciently absorbed in the small intestine when transit time was shortened (Holgate & Read, 1983; Chapman et al, 1985) . Thus, its excretion in feces may have been enhanced with short transit time, allowing more production of propionate and butyrate (Macfarlane & Englyst, 1986; Scheppach et al, 1988) . On the other hand, increased SCFA production was associated with a lower pH, a factor which in itself can alter fermentation end-products (Finlayson, 1986) . Moreover, we previously showed (El Ou®r et al, 1996) that fast transit time is associated with reduced methanogenic bacteria and increased sulfate-reducing bacteria (SRB). The inverse relation between methanogenic bacteria and SRB stool counts is well documented (Gibson et al, 1990) and some data indicate that fecal methanogens utilise H 2 more ef®ciently than do SRB (Strocchi et al, 1991) . This may explain why more net production of H 2 was found in our batch culture during the cisapride period. Hydrogen accumulation inhibits H 2 production from NADH, so that NAD regeneration then occurs mainly via the production of the reduced bioproducts (propionate and butyrate). In the presence of methanogenic bacteria, all of the H 2 is used to reduce CO 2 to methane gas. Thus by consuming H 2 and preventing its accumulation, methanogens allow hydrogen-forming bacteria to regenerate NAD from NADH, which favors the production of acetate and decreases the production of other electron sinks such as butyrate. This has also been clearly demonstrated in batch pure culture (Kengen & Stams, 1994) in which hydrogen partial pressure strongly in¯uenced the metabolic pathway involved. Contrary to the prevailing opinion, increase in SRB could therefore have bene®cial effects via enhanced butyrate production.
Our ®ndings are in agreement with the observed differences in the extent of substrate fermentation and SCFA pro®les due to the fecal inoculum donor and con®rm that different individuals possess colonic micro¯ora with somewhat different activities (Bourquin et al, 1992) . McBurney and Thompson (1989) also noted differences in substrate disappearance for different inoculum donors, which led to their suggestion that at least three inoculum donors must be used in in vitro studies of human ®ber fermentation. The factors affecting the composition and activities of colonic ora, which could account for these inter-individual variations, are largely unknown, although various factors including age, diet, colonic pH and microbial interactions, colonic supply and availability of nutrients, bile acids and sulfate, and microbial adaptation to metabolize these substrates (Gorbach et al, 1967; Hill, 1981; Wrong et al, 1981; Weaver et al, 1989; Macfarlane & Cummings, 1991; Florin & Jabbar, 1994) seem to be important. Our results show that transit time, either directly andaor by its effects on the nature and amount of substrate delivered to the colon, may be an important factor in accounting for interindividual differences in its composition (EI Ou®r et al, 1996) and in certain of its activities.
